EP3027651
Affúkósýleruð AND-FGFR2IIIB mótefni
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
31.7.2014EP published:
27.2.2019EP application number:
14752705.5
EP translation filed:
29.3.2019Grant published:
15.4.2019EPO information:
European Patent Register
Max expiry date:
30.7.2034Expiry date:
30.7.2026Next due date:
31.7.2026
Title:
AFUCOSYLATED ANTI-FGFR2IIIB ANTIBODIES
Timeline
Today
31.7.2014EP application
27.2.2019EP Publication
29.3.2019Translation submitted
15.4.2019Registration published
30.7.2026Expires
Owner
Name:
Five Prime Therapeutics, Inc.Address:
111 Oyster Point Boulevard, 94080, South San Francisco, CA, US
Inventor
Name:
HARDING, ThomasAddress:
South San FranciscoCalifornia, US
Name:
PIERCE, KristenAddress:
South San FranciscoCalifornia, US
Name:
PATIL, NamrataAddress:
South San FranciscoCalifornia, US
Name:
BRENNAN, ThomasAddress:
South San FranciscoCalifornia, US
Name:
HAMBLETON, JulieAddress:
South San FranciscoCalifornia, US
Agent
Name:
Orsnes PatentAddress:
Sentvedvej 23, DK
Priority
Number:
201361861198 PDate:
1.8.2013Country:
US
Number:
201361901732 PDate:
8.11.2013Country:
US
Number:
201461933632 PDate:
30.1.2014Country:
US
Classification
Categories:
A61K 39/395, A61K 45/06, A61K 31/337, A61K 33/24, C07K 16/28, A61K 31/513, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 5.6.2019
Expires: 30.7.2020
Payer: Árnason Faktor
Number: 7
Paid: 12.6.2020
Expires: 30.7.2021
Payer: Árnason Faktor ehf.
Number: 8
Paid: 8.6.2021
Expires: 30.7.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 21.6.2022
Expires: 30.7.2023
Payer: Patice ehf.
Number: 10
Paid: 22.6.2023
Expires: 30.7.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 19.6.2024
Expires: 30.7.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 14.7.2025
Expires: 30.7.2026
Payer: Árnason Faktor ehf.